Delivery Order SPE2DE24DA017-SPE2D626F22LC
- Not listed
- Arthrex Inc., a leading orthopedic medical device manufacturer headquartered in Naples, Florida, was awarded a delivery order valued at $3,852.00 for an ACP Kit Series I on January 13, 2026, with an ultimate completion date of January 16, 2026. This fixed-price delivery order with economic price adjustment carries no set-aside designation and is being performed at Arthrex's Naples facility. The award is funded through the Defense Logistics Agency's Medical Supply Chain, which supports the...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a $1,155.60 fixed-price delivery order (4568302724) for an ACP Kit Series I on May 19, 2025, with an ultimate completion date of May 22, 2025. This delivery order, issued by the Defense Logistics Agency's Medical Supply Chain, carries no set-aside designation, reflecting Arthrex's strong competitive position in the federal orthopedic medical device marketplace. The work will be...
- Arthrex Inc., a leading manufacturer of minimally invasive orthopedic medical technologies headquartered in Naples, Florida, was awarded a delivery order valued at $1,817.64 on January 12, 2026, with an ultimate completion date of January 15, 2026. The contract, designated as a fixed-price delivery order with economic price adjustment provisions, is funded by the Defense Logistics Agency's Medical Supply Chain and will be performed in Naples, Florida. This award was issued without a set-aside...
- Arthrex Inc., headquartered in Naples, Florida, was awarded a $43,078.62 delivery order for an ACP Kit Series II on June 26, 2025, by the Defense Logistics Agency's Medical Supply Chain. The contract, which employs fixed-price pricing with economic price adjustment terms, is scheduled for completion by July 1, 2025, and will be performed at Arthrex's Naples facility. This delivery order was issued without a set-aside designation, reflecting Arthrex's strong competitive standing in the federal...
- Arthrex Inc., a global leader in minimally invasive orthopedic medical technologies headquartered in Naples, Florida, was awarded a delivery order valued at $6,604.20 on August 25, 2025, for an ACP Kit Series I through the Defense Logistics Agency's Medical Supply Chain. This fixed-price contract with economic price adjustment provisions is scheduled for completion by August 28, 2025, and will be performed at Arthrex's Naples, Florida facility. The award carries no set-aside designation,...
- Arthrex Inc., a Naples, Florida-based orthopedic medical device manufacturer, received a delivery order award on July 25, 2025, for an ACP + ACD-A Kit valued at $3,554.10. This fixed-price delivery order with economic price adjustment adjustment carries an ultimate completion date of July 30, 2025, and will be performed in Naples, Florida. The award was made without a set-aside designation, reflecting Arthrex's competitive standing in the federal marketplace. The funding agency is the Defense...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a delivery order valued at $2,889.00 for an ACP Kit Series I on August 13, 2025, with a completion date of August 18, 2025. This fixed-price delivery order with economic price adjustment was issued through the Defense Logistics Agency's Medical Supply Chain, a defense-oriented federal agency supporting the Department of Defense and Department of Veterans Affairs healthcare systems. The...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a delivery order valued at $1,926.00 for an ACP Kit Series I. This fixed-price delivery order with economic price adjustment authority was issued by the Defense Logistics Agency's Medical Supply Chain on September 16, 2025, with completion scheduled for September 19, 2025. The award carries no set-aside designation, reflecting Arthrex's strong competitive position in the federal...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a delivery order valued at $6,741.00 for an ACP Kit Series I on June 18, 2025, with an ultimate completion date of June 24, 2025. This fixed-price contract with economic price adjustment was issued by the Defense Logistics Agency's Medical Supply Chain, a defense-focused federal agency. The contract carries no set-aside designation, reflecting Arthrex's strong competitive position in...
- Arthrex Inc., a leading global manufacturer of minimally invasive orthopedic medical technologies headquartered in Naples, Florida, was awarded a delivery order valued at $4,815.00 for an ACP Kit Series I on October 30, 2025, with an ultimate completion date of November 4, 2025. This fixed-price delivery order with economic price adjustment carries no set-aside designation and is performed at Arthrex's Naples, FL facility. The award is funded through the Defense Logistics Agency's Medical Supply...
- SPE2DE24DA017Indefinite Delivery Contract
- SPE2DE24DA017-SPE2D626F22LCDelivery Order
Arthrex Inc., a leading orthopedic medical device manufacturer headquartered in Naples, Florida, was awarded a fixed-price delivery order valued at $1,926.00 for an ACP Kit Series I on January 23, 2026, with an ultimate completion date of January 28, 2026. This delivery order is issued without a set-aside designation and represents work performed at Arthrex's Naples, Florida facility. The award is funded through the Defense Logistics Agency's Medical Supply Chain, which provides orthopedic medical technologies and surgical instruments to support the healthcare needs of military personnel and veterans. This delivery order is issued under Arthrex's larger Indefinite Delivery Contract (SPE2DE24D0020) with the Defense Logistics Agency's Medical Supply Chain, valued at $471 million and effective through September 1, 2029. The master contract authorizes procurement of a comprehensive range of orthopedic products including surgical implants, arthroscopic instruments, joint replacement technologies, and biologics for Department of Veterans Affairs medical centers and Department of Defense healthcare facilities nationwide. Arthrex serves as the prime contractor with no identified subcontractors, demonstrating the company's established capacity to fulfill federal orthopedic surgical requirements directly across multiple surgical specialties.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 1/22/26 |